Navigation Links
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Date:8/4/2009

ry approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2008, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
2. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
3. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
4. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
5. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
6. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
7. Harbinger Research Initiates Coverage on HearAtLast
8. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
9. MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma
10. Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease
11. Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... delivered ,, WASHINGTON, Dec. 15 ... that healthcare reform does not override the prostate ... in 37 states. ,, Prostate cancer screening is ... and individuals who are identifiable as high risk, ... a family history of prostate cancer. The American ...
(Date:12/15/2009)... MENLO PARK, Calif., Dec. 15 ... its position in the pharmaceutical and bio-tech ... (Caduceus Marketing Research). Over the past 11 ... panel, the Physicians Consulting Network (PCN®), which ... healthcare professionals covering both primary care and ...
(Date:12/15/2009)... Team In Training (TNT), The Leukemia ... sports training program, has reached a remarkable milestone ... research and patient services. ,, For more than ... endurance sports training program, preparing amateurs and seasoned ... 100-mile century cycle ride or hike adventure. Through ...
(Date:12/15/2009)... NEW YORK, Dec. 15 The following are ... Attorney General for the criminal division, at the ... you, Secretary Sebelius. And thank you for the ... the HEAT initiative. ,, Together, our Departments ... lasting results. ,, We,ve made tremendous progress in ...
(Date:12/15/2009)... Mass., Dec. 15 North American application ... in November year-over-year, according to the MIB ... insurance applications over the past three months have ... levels of -1.6%, to flat at November,s close, ... their interest in the benefits available from life ...
Breaking Medicine News(10 mins):Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... to a long-standing assumption that blood vessel cells in ... a new study unequivocally demonstrates that tumor blood vessel ... Cell Press in the September issue of the journal ... that are atypically stem cell-like and have the potential ...
... coaching pioneer to discuss growing popularity of health coaching, advantages of ... , ... Cincinnati, OH (PRWEB) September 8, 2008 -- Hummingbird ... coaching at the Medical Wellness Forum, scheduled for September 9-11, 2008 ...
... a company established in 2002, will begin to market "Platinum ... of NZymeCeuticals, Inc., announced Friday the company will begin to ... as "PN20K" to North and South America. , ... ...
... appear to lower a man,s PSA level, the blood biomarker ... is at risk of prostate cancer. , But the authors ... journal Cancer , caution that men shouldn,t take the ... , "We showed that men who regularly took certain ...
... in Molecular,Testing and Personalized Medicine, NORTHFIELD, Ill., ... a transformation point. Molecular testing and the promise,of ... treated. Digital,slides and other imaging technologies will change ... is taking a leadership role in,making sure that ...
... how theoretical ,anti-cloak, could bring objects out of hiding ... case someone develops a cloak of invisibility, a team ... the objects it hides. , According to a paper ... an invisibility cloak would allow invisible objects to be ...
Other Medicine News:Health News:Apples and oranges: Tumor blood vessel cells are remarkably atypical 2Health News:Hummingbird Coaching Services to Speak on Wellness Coaching and Positive Psychology at Medical Wellness Forum 2Health News:Hummingbird Coaching Services to Speak on Wellness Coaching and Positive Psychology at Medical Wellness Forum 3Health News:NZymeCeuticals Announces the Introduction of New Bulk Ingredient 'Platinum Nattokinase' (PN20K) to Dietary Supplement Industry 2Health News:Common painkillers lower levels of prostate cancer biomarker 2Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Systemic ... and Market Forecasts to 2015 ... Systemic Lupus Erythematosus - Drug Pipeline ... ,, Summary ,, GlobalData, ...
(Date:12/15/2009)... EnzySurge Ltd.,(EnzySurge), a provider of ... market, announced today that it has received ... (FDA) to market its new,SilverStream(TM) solution for ... Over-the-Counter version of the SilverStream product. , ... developer of the DermaStream(R) product line.,DermaStream is ...
(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 NxStage Medical, ... of innovative dialysis products, today announced that a ... partners will be embarking on a week-long, conventional ... cyclers. The cruise, dubbed the "2010 Freedom ... from Miami, Fla. on January 3, 2010 and ...
Breaking Medicine Technology:Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4NOAA deploys new smart buoy off Annapolis 10694 1NOAA deploys new smart buoy off Annapolis 10694 2Energy saving powder 10692 1Energy saving powder 10692 2Energy saving powder 10692 3Largest ever database for liver proteins may lead to treatments for hepatitis 10690 1
... Pa., May 14 The Quigley,Corporation (Nasdaq: ... by its wholly owned subsidiary, Quigley Pharma Inc., ... activity of its compound,QR448(a). The compound was administered ... Virus (IBV). The data from the study indicated,that ...
... Host Webcast to Review Data Tuesday, May 13 at 1:00 p.m. EDT ... ... Calif., May 13 /PRNewswire-FirstCall/,-- XTENT, Inc. (Nasdaq: XTNT ) today announced ... safety and,efficacy of the Custom NX(R) drug eluting stent (DES) system for ...
Other Medicine Technology:Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4
... can be used with Portex® reusable or ... blades with long-lasting bronze fiber-optic bundles provide ... routine use., ,The laryngoscope blades are ... from infant to large adult, and in ...
... intubation system. Providing an unobstructed view of ... for many types of intubations., ,A ... the patented Glidescope blade. Clear images are ... a monitor screen. An LED light source ...
... Articulating Tip Laryngoscopes are the ... Industry. The articulating tip aids ... an improved view of epiglottis. ... Optic styles. We guarantee your ...
... CCR Medical's Articulating Tip ... units in the Industry. The ... intubation by providing an improved ... Conventional and Fiber Optic styles. ...
Medicine Products: